Jinhe Biotechnology CO., LTD.

SZSE:002688 Stock Report

Market Cap: CN¥4.9b

Jinhe Biotechnology Management

Management criteria checks 4/4

Jinhe Biotechnology's CEO is Changxian Xie, appointed in Nov 2007, has a tenure of 17.42 years. directly owns 0.44% of the company’s shares, worth CN¥21.22M. The average tenure of the management team and the board of directors is 10.8 years and 10.5 years respectively.

Key information

Changxian Xie

Chief executive officer

CN¥575.9k

Total compensation

CEO salary percentagen/a
CEO tenure17.4yrs
CEO ownership0.4%
Management average tenure10.8yrs
Board average tenure10.5yrs

Recent management updates

Recent updates

Sentiment Still Eluding Jinhe Biotechnology CO., LTD. (SZSE:002688)

Mar 27
Sentiment Still Eluding Jinhe Biotechnology CO., LTD. (SZSE:002688)

Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

May 27
Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

May 13
Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 13
Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

CEO

Changxian Xie (62 yo)

17.4yrs

Tenure

CN¥575,900

Compensation

Mr. Changxian Xie serves as General Manager at Jinhe Biotechnology CO., LTD. since November 27, 2007 and serves as its Director since November 27, 2007.


Leadership Team

NamePositionTenureCompensationOwnership
Changxian Xie
GM & Director17.4yrsCN¥575.90k0.44%
CN¥ 21.2m
You Shan Niu
Financial Director10.7yrsCN¥306.50k0.040%
CN¥ 1.9m
Zhi Jun Wang
Deputy GM & Director11yrsCN¥696.00kno data
Yueqing Wang
Deputy GM & Non-Independent Director1.9yrsCN¥305.90k0.040%
CN¥ 1.9m
Manman Lu
Board Secretary & Director4.1yrsCN¥394.80k1%
CN¥ 48.9m
Zhi Sheng Wang
Deputy General Manager11yrsCN¥246.10kno data
Ying Chun Liu
Deputy General Manager14.3yrsCN¥307.80k0.084%
CN¥ 4.1m
Yingzhen Guan
Deputy General Manager8.3yrsCN¥308.90k0.040%
CN¥ 1.9m
Lihang Zhou
Chief Accounting Officerno datano datano data

10.8yrs

Average Tenure

55yo

Average Age

Experienced Management: 002688's management team is seasoned and experienced (10.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Changxian Xie
GM & Director17.4yrsCN¥575.90k0.44%
CN¥ 21.2m
Zhi Jun Wang
Deputy GM & Director11yrsCN¥696.00kno data
Yueqing Wang
Deputy GM & Non-Independent Director1.9yrsCN¥305.90k0.040%
CN¥ 1.9m
Manman Lu
Board Secretary & Director1.9yrsCN¥394.80k1%
CN¥ 48.9m
Dongxiao Wang
Chairman17.4yrsCN¥880.50k31.96%
CN¥ 1.6b
Fu Zhong Li
Vice Chairman of Board of Directors 17.4yrsCN¥610.00k0.68%
CN¥ 33.2m
Qian Sui Zhang
Chairman of the Supervisory Board9.9yrsno datano data
Jian Xiong Yao
Shareholder Representative Supervisor11yrsno datano data
Liu Ji Zheng
Employee Representative Supervisor11.1yrsno datano data
Minpu Yao
Independent Director4.9yrsCN¥82.80kno data
Xiaoyan Xie
Independent Director4.9yrsCN¥82.80kno data
Wenbing Lu
Independent Director4.9yrsCN¥82.80kno data

10.5yrs

Average Tenure

56.5yo

Average Age

Experienced Board: 002688's board of directors are seasoned and experienced ( 10.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/28 15:42
End of Day Share Price 2025/04/28 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jinhe Biotechnology CO., LTD. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xie ZhiyouChina Galaxy Securities Co., Ltd.
Sha ZhouChina Merchants Securities Co. Ltd.